Fibromyalgia Treatment Market Share

  • Report ID: 4467
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Fibromyalgia Treatment Market Share

APAC Market Statistics

The Asia-Pacific market is anticipated to increase steadily throughout the course of the forecast period. Aspects such as the growing number of fibromyalgia patients, along with rising healthcare spending and developing healthcare infrastructure, are predicted to boost the market growth in the Asia Pacific.

North American Market Forecast

The North America fibromyalgia treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. It is backed by the radically increasing prevalence of fibromyalgia, and the rising awareness among people regarding fibromyalgia in the region. As per the Centers for Disease Control and Prevention, fibromyalgia affects approximately 4 million adults in the United States, accounting for approximately 2% of the adult population.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4467
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of fibromyalgia treatment is evaluated at USD 243.61 million.

The fibromyalgia treatment market size was over USD 226.91 million in 2024 and is anticipated to exceed USD 710.71 million by the end of 2037, witnessing over 9.1% CAGR during the forecast period i.e., between 2025-2037. Worldwide growing incidences of road accidents, surge in post-traumatic stress disorder (PTSD), and worldwide boost in geriatric population will drive the market growth.

Asia Pacific industry is projected to grow steadily through 2037, impelled by growing number of fibromyalgia patients, along with rising healthcare spending and developing healthcare infrastructure.

The major players in the market include Pfizer Inc., AbbVie Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Aptinyx Inc., Tonix Pharmaceuticals Holding Corp., Virios Therapeutics.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample